Global Monoclonal Antibodies Market Set to Reach USD 494.7 Billion by 2031, With a Sustainable CAGR Of 12.7%| Growth Market Reports

PUNE, India, Feb. 7, 2023 /PRNewswire/ -- According to a recent market study published by Growth Market Reports, titled, "Monoclonal Antibodies Market by Source (Murine, Chimeric, Humanized, and Human), Indication (Cancer, Autoimmune Diseases, Neurological Diseases, Infectious Diseases, and Others), End-user (Hospitals, Research Institutes, and Others), and Region: Size, Share, Trends and Opportunity Analysis, 2023-2031", the market size was USD 168.69 billion in 2022 and is expected to reach USD 494.78 billion expanding at a CAGR of 12.5% by the end of 2031. The market growth is attributed to the increasing use of monoclonal antibodies to cure cancer and infectious diseases.

Key Market Players Profiled in the Report

• AbbVie Inc.
• Janssen Biotech, Inc.
• Amgen Inc.
• AstraZeneca
• Lilly
• Merck & Co., Inc.
• Abbott
• Novartis AG
• Pfizer Inc.
• Takeda Pharmaceutical Company Limited

Download PDF Sample here: https://growthmarketreports.com/request-sample/4881

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include source, indication, and competitor analysis.

This report also includes a complete analysis of industry players and covers their latest developments, product portfolio, pricing, mergers, acquisitions, and collaborations. Moreover, it provides crucial strategies that are helping market players to expand their market share.

Highlights on the segments of the Monoclonal Antibodies Market

Based on the source, the monoclonal antibodies market is segmented into murine, chimeric, humanized, and human. The human segment is projected to account for a substantial share of the monoclonal antibodies market during the forecast period. The human-type monoclonal antibody is made of human protein and does not induce immunogenicity.

On the basis of indication, the market is fragmented into cancer, autoimmune diseases, neurological diseases, infectious diseases, and others. The cancer segment is projected to hold a significant share of the market during the forecast period, as the prevalence of cancer is extremely high.

For Any Questions on This Report: https://growthmarketreports.com/enquiry-before-buying/4881

Based on the end-user, the market is categorized into hospitals, research institutes, and others. The hospital segment is expected to hold a major share of the market during the forecast period, as hospitals are a common treatment spot for the treatment of various diseases as compared with specialty centers.

On the basis of region, the global market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Europe is expected to hold a substantial market share during the forecast period, owing to increasing R&D activities for patients with complicated and untreated diseases.

To Buy the Complete Report: https://growthmarketreports.com/report/monoclonal-antibodies-market-global-industry-analysis

Key Takeaways from the Study:

• Increase in prevalence of cancer, increase in demand for cost-efficient biosimilar monoclonal antibodies, and increase in R&D activities in genomics coupled with the introduction of technologically advanced genetic platforms, such as next-generation sequencing are the major factors that drive the growth of the market.
• Monoclonal antibodies are emerging as a significant class of therapeutic agents for the treatment of various human diseases. The treatments available for the diseases are the outcome of previous R&D activities in the field of monoclonal antibodies.
• The use of rise of drug-resistant bacteria with the rapid development of neutralizing monoclonal antibodies to treat infectious diseases was needed, and the increasing usage of monoclonal antibodies to treat other infectious diseases can further boost the global market.
• Monoclonal antibodies are used for clinical trials to research additional applications to use across various branches of science.
• The market in North America is expected to hold a major share of the global market owing to the presence of a well-established medical sector and a high number of FDA approvals for monoclonal antibodies can drive the market.

Read 312 Pages Research Report with Detailed TOC on "Monoclonal Antibodies Market by Source (Murine, Chimeric, Humanized, and Human), Indication (Cancer, Autoimmune Diseases, Neurological Diseases, Infectious Diseases, and Others), End-user (Hospitals, Research Institutes, and Others), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast, 2023 – 2031"

Get Full Access to this Report: https://growthmarketreports.com/checkout/4881

Key Segments Covered

Source

• Murine
• Chimeric
• Humanized
• Human

Indication

• Cancer
• Autoimmune Diseases
• Neurological Diseases
• Infectious Diseases
• Others

End-user

• Hospitals
• Research Institutes
• Others

Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Other Related Reports:

• Laboratory Proficiency Testing Market by Industry Scope (Clinical Diagnostics [Clinical Chemistry, Immunochemistry, Hematology, Oncology, Molecular Diagnostics {PCR, and Others}, Coagulation], Pharmaceuticals [Biologics {Vaccines, Blood, and Tissues}, and Others], and Microbiology [Pathogen Testing, Sterility Testing, Endotoxin & Pyrogen Testing, Growth Promotion Testing, and Other Microbial Testing], and Others), Technology (Cell Culture, Spectrometry, Polymerase Chain Reaction (PCR), Chromatography, Immunoassays, and Others), End-uses (Hospitals, Contract Research Organizations, Pharmaceutical & Biotechnology Companies, Academic Research, and Diagnostic Laboratories [Independent Laboratories and Specialty Laboratories]), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
• Global Cancer/Tumor Profiling Market by Technology (Immunoassays, In Situ Hybridization, Mass Spectrometry, Microarrays, Next-generation Sequencing, Polymerase Chain Reaction, and Others), Cancer Types (Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, Prostate Cancer, and Other Cancers), Biomarker Types (Genetic Biomarkers, Protein Biomarkers, and Other Biomarkers), Applications (Research [Biomarker Discovery and Personalized Medicine] and Clinical [Diagnostics, Prognostics, Monitoring & Treatment, and Screening]), and Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Global Industry Analysis, Growth, Share, Size, Trends, and Forecast From 2022 To 2030
• Global Cancer Monoclonal Antibodies Market by Type (Murine Antibodies, Chimeric and Humanised Antibodies, Fully Humanized Antibodies, Others), By Application (Liver, Breast, Blood, Brain, Hodgkins, and Non-Hodgkins lymphoma, Colorectal, Leukemia, Others) and Region (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa), Forecast To 2028
• Global Polyclonal Antibodies Market by Type (Primary Antibody, Secondary Antibody), By Application (Academic Research, Commercial, ) And By Region (North America, Latin America, Europe, Asia Pacific a,nd Middle East & Africa), Forecast From 2022 To 2030

About Growth Market Reports:

Growth Market Reports provides global enterprises as well as small & medium businesses with unmatched quality of "Market Research Reports" and "Industry Intelligence Solutions". Growth Market Reports has a targeted view to provide business insights and consulting to assist its clients in making strategic business decisions and achieving sustainable growth in their respective market domains.

Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, and secondary research & consumer surveys.

Contact:

Alex Mathews 
7^th Floor, Siddh Icon,
Baner Road, Pune.
Maharashtra – 411045. India.
Phone: +1 909 414 1393  
Email: sales@growthmarketreports.com  
Web: https://growthmarketreports.com   
Twitter: https://twitter.com/growth_reports  
LinkedIn: https://www.linkedin.com/company/growth-market-report/

Logo: https://mma.prnewswire.com/media/1980656/Growth_Market_Reports_Logo1.jpg